News & Insights

PicnicHealth launched its life science product today to enable high-quality, low-burden research for life sciences companies and patients.

Q&A with PicnicHealth Chief Commercial Officer, Rachael Thomas Higgins

PicnicHealth announces the appointment of Rachael Thomas Higgins as Chief Commercial Officer

In honor of Rare Disease Day, we dived into an insightful Q&A session with PicnicHealth's Chief Medical Officer, Daniel R. Drozd, an MD at the forefront of pioneering healthcare research.

PicnicHealth announced the launch of a new study portal to facilitate faster, more accurate observational research.

We’re thrilled to share that #PicnicHealthGivesBack, our annual giving campaign, has returned this year. From now until January 5, 2024, we’re donating to The American Kidney Fund (AKF) and The Chandler Project for each new PicnicHealth sign-up, up to $6k. Join PicnicHealth today to make an even bigger impact.

PicnicHealth announced the acquisition of AllStripes, a platform dedicated to generating evidence about the rare disease community. This strategic consolidation establishes PicnicHealth as the leading patient-centric evidence generation partner within a rapidly evolving life sciences landscape.

PicnicHealth announced the acquisition of AllStripes, a platform dedicated to generating evidence about the rare disease community. This strategic consolidation establishes PicnicHealth as the leading patient-centric evidence generation partner within a rapidly evolving life sciences landscape.

PicnicHealth is thrilled to announce our entry into the real-world data market for oncology. Leveraging our successes in chronic and rare diseases, we're now dedicated to advancing oncology research by collaborating directly with people living with cancer.

PicnicHealth is excited to announce that we are expanding our long-term partnership with Roche and Genentech to better understand brain health and accelerate neurological disease research using real-world data.

CureDuchenne and PicnicHealth Announce Real-World Evidence-Focused Partnership to Incorporate Participant Medical Records into CureDuchenne Link

PicnicHealth, a patient-centered health technology company, and Bristol Myers Squibb are working together to leverage real-world evidence to study symptomatic obstructive hypertrophic cardiomyopathy patients within the DISCOVER-HCM Registry.

We are excited to launch a new Lupus Nephritis real-world data research cohort that arms researchers with powerful data to support clinical research programs and drive evidence generation now and into the future.

With that, I’m very happy to share that PicnicHealth has raised a $60m Series C to build the deep, complete, and clinically-rich real-world data sets needed in 30 new diseases. As always, we’ll do this by partnering directly with patients to give them control over their own data.

PicnicHealth is excited to partner with Komodo Health to enrich its patient-centered real-world data Research Platform. This collaboration will enable PicnicHealth to unlock rich new insights about complex diseases and treatment outcomes.

We’re excited to announce the formation of our Scientific Advisory Board (SAB) and welcome inaugural members, including Robert Kaplan, PhD, Jeffrey Brown, PhD, and Milena Gianfrancesco, PhD, MPH.

PicnicHealth is excited to partner with Komodo Health to enrich its patient-centered real-world data Research Platform. This collaboration will enable PicnicHealth to unlock rich new insights about complex diseases and treatment outcomes.

PicnicHealth is excited to announce $35 million in funding, including a $25 million Series B led by Felicis Ventures, and a previously-unannounced $10 million Series A led by Amplify Partners, which also participated in the Series B.

Announcing the official launch of PicnicHealth's scientific research platform. PicnicHealth is gathering medical records data from proactively consenting patients, de-identifying it to ensure patient data privacy, and then aggregating it with the goal of deepening the scientific understanding of serious diseases. This data, known as “real-world data” helps researchers better understand what diseases look like outside of the controlled setting of clinical trials where research has traditionally been done.